Regeneron Pharmaceuticals, Inc. holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 14,876 | $9,434,805 | 0.69% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 2, 2025 |
| June 30, 2025 | 9,876 | $5,184,900 | 0.33% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 1, 2025 |
| Sept. 30, 2025 | 31,362 | $17,633,912 | 1.02% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 31, 2025 |
| Dec. 31, 2025 | 31,362 | $24,207,387 | 1.37% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 13, 2026 |
| March 31, 2026 | 31,362 | $24,231,536 | 1.59% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 1, 2026 |
| June 30, 2026 | 36,362 | $22,673,161 | 1.34% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 31, 2026 |
| Sept. 30, 2026 | 36,362 | $27,572,214 | 1.61% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 2, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.